-+ 0.00%
-+ 0.00%
-+ 0.00%

Vanda Pharmaceuticals appoints Charles Duncan to board of directors

PUBT·04/22/2026 21:14:23
Listen to the news
Vanda Pharmaceuticals appoints Charles Duncan to board of directors
  • Vanda Pharmaceuticals appointed Charles Duncan to board of directors, effective April 22, 2026.
  • Board expanded to seven directors, including six independent directors.
  • Duncan is president of Sulci Advisors, life sciences advisory firm founded in September 2025.
  • He previously served as managing director and senior biotechnology analyst at Cantor Fitzgerald from July 2018 to June 2025.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vanda Pharmaceuticals Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202604221713PR_NEWS_USPR_____PH41541) on April 22, 2026, and is solely responsible for the information contained therein.